PIK3CA c.1822_1823delinsCG ;(p.D608R)

Variant ID: 3-178937434-GA-CG

NM_006218.2(PIK3CA):c.1822_1823delinsCG;(p.D608R)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.

Journal Of Experimental & Clinical Cancer Research : Cr
Camorani, Simona S; Passariello, Margherita M; Agnello, Lisa L; Esposito, Silvia S; Collina, Francesca F; Cantile, Monica M; Di Bonito, Maurizio M; Ulasov, Ilya V IV; Fedele, Monica M; Zannetti, Antonella A; De Lorenzo, Claudia C; Cerchia, Laura L
Publication Date: 2020-09-07

Variant appearance in text: PI3K: D608R
PubMed Link: 32892748
Variant Present in the following documents:
  • Main text
  • 13046_2020_Article_1694.pdf
View BVdb publication page